| Year |
Citation |
Score |
| 2020 |
Ghassemi S, Martinez-Becerra F, Master A, Richman S, Heo D, Leferovich J, Tu Y, Garcia-Canaveras J, Ayari A, Lu Y, Wang A, Rabinowitz J, Milone M, O'Connor R. Novel media formulations to enhance Chimeric Antigen Receptor (CAR) T-cell potency and anti-tumor cell function for adoptive immunotherapy Cytotherapy. 22: S133. DOI: 10.1016/J.Jcyt.2020.03.260 |
0.444 |
|
| 2017 |
Lu Y, Hu Z, Mangala LS, Stine ZE, Hu X, Jiang D, Xiang Y, Zhang Y, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Demarzo A, Sood AK, Zhang L, Dang CV. MYC targeted long non-coding RNA DANCR promotes cancer in part by reducing p21 levels. Cancer Research. PMID 29180471 DOI: 10.1158/0008-5472.Can-17-0815 |
0.627 |
|
| 2015 |
Xiang Y, Stine ZE, Xia J, Lu Y, O'Connor RS, Altman BJ, Hsieh AL, Gouw AM, Thomas AG, Gao P, Sun L, Song L, Yan B, Slusher BS, Zhuo J, et al. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. The Journal of Clinical Investigation. 125: 2293-306. PMID 25915584 DOI: 10.1172/Jci75836 |
0.325 |
|
| 2014 |
Doherty JR, Yang C, Scott KE, Cameron MD, Fallahi M, Li W, Hall MA, Amelio AL, Mishra JK, Li F, Tortosa M, Genau HM, Rounbehler RJ, Lu Y, Dang CV, et al. Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis. Cancer Research. 74: 908-20. PMID 24285728 DOI: 10.1158/0008-5472.Can-13-2034 |
0.6 |
|
| 2012 |
Chaluvally-Raghavan P, Zhang F, Pradeep S, Hee-Dong H, Lu Y, Borresen-Dale A, Flores E, Sood A, Mills G. Abstract P5-10-03: OncomiR-569 deregulate p53 pathway and initiate breast oncogenesis Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P5-10-03 |
0.518 |
|
| Show low-probability matches. |